Seno gets $2m in state funding:
This article was originally published in Clinica
Executive Summary
Opto-acoustic technology specialist Seno Medical Instruments has been awarded $2m from the Texas Emerging Technology Fund (TETF), a $200m government investment programme aimed at financing local advancing technology projects. This investment allows San Antonio, Texas-based Seno to further develop its breast cancer imaging technology, and work towards implementing initial clinical trials on technology at the Cancer Therapy and Research Center, and the University of Texas Health Science Center. The company is aiming to provide a device that uses optics and acoustics, instead of x-ray radiation, to capture an accurate image of a tumour.
You may also be interested in...
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.